The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infectious Immunology-Global Market Insights and Sales Trends 2025
Synopsis
Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.
The global Infectious Immunology market size is expected to reach US$ 37790 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Infectious Immunology in various end use industries. The expanding demands from the HIV, TB, HBV and HCV and Pneumonia, are propelling Infectious Immunology market. Diagnostic Kits, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Immunology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infectious Immunology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Immunology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Immunology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Immunology covered in this report include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories, Dr. Reddy’s Laboratories, AbbVie Inc, Janssen Global Services, Johnson & Johnson and Amgen Inc, etc.
The global Infectious Immunology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientifics
Bio-Rad Laboratories
Dr. Reddy’s Laboratories
AbbVie Inc
Janssen Global Services
Johnson & Johnson
Amgen Inc
Pfizer Inc
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp
UCB SA
Allergan
Global Infectious Immunology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Immunology market, Segment by Type:
Diagnostic Kits
Instruments
Reagents
Global Infectious Immunology market, by Application
HIV
TB
HBV and HCV
Pneumonia
Malaria
Inflammatory Bowel Diseases
Auto Immune Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Immunology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.
The global Infectious Immunology market size is expected to reach US$ 37790 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Infectious Immunology in various end use industries. The expanding demands from the HIV, TB, HBV and HCV and Pneumonia, are propelling Infectious Immunology market. Diagnostic Kits, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Immunology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infectious Immunology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Immunology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Immunology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Immunology covered in this report include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories, Dr. Reddy’s Laboratories, AbbVie Inc, Janssen Global Services, Johnson & Johnson and Amgen Inc, etc.
The global Infectious Immunology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientifics
Bio-Rad Laboratories
Dr. Reddy’s Laboratories
AbbVie Inc
Janssen Global Services
Johnson & Johnson
Amgen Inc
Pfizer Inc
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp
UCB SA
Allergan
Global Infectious Immunology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Immunology market, Segment by Type:
Diagnostic Kits
Instruments
Reagents
Global Infectious Immunology market, by Application
HIV
TB
HBV and HCV
Pneumonia
Malaria
Inflammatory Bowel Diseases
Auto Immune Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Immunology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infectious Immunology
1.1 Infectious Immunology Market Overview
1.1.1 Infectious Immunology Product Scope
1.1.2 Infectious Immunology Market Status and Outlook
1.2 Global Infectious Immunology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infectious Immunology Market Size by Region (2018-2029)
1.4 Global Infectious Immunology Historic Market Size by Region (2018-2023)
1.5 Global Infectious Immunology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infectious Immunology Market Size (2018-2029)
1.6.1 North America Infectious Immunology Market Size (2018-2029)
1.6.2 Europe Infectious Immunology Market Size (2018-2029)
1.6.3 Asia-Pacific Infectious Immunology Market Size (2018-2029)
1.6.4 Latin America Infectious Immunology Market Size (2018-2029)
1.6.5 Middle East & Africa Infectious Immunology Market Size (2018-2029)
2 Infectious Immunology Market by Type
2.1 Introduction
2.1.1 Diagnostic Kits
2.1.2 Instruments
2.1.3 Reagents
2.2 Global Infectious Immunology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infectious Immunology Historic Market Size by Type (2018-2023)
2.2.2 Global Infectious Immunology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infectious Immunology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infectious Immunology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infectious Immunology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infectious Immunology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infectious Immunology Revenue Breakdown by Type (2018-2029)
3 Infectious Immunology Market Overview by Application
3.1 Introduction
3.1.1 HIV
3.1.2 TB
3.1.3 HBV and HCV
3.1.4 Pneumonia
3.1.5 Malaria
3.1.6 Inflammatory Bowel Diseases
3.1.7 Auto Immune Diseases
3.1.8 Others
3.2 Global Infectious Immunology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infectious Immunology Historic Market Size by Application (2018-2023)
3.2.2 Global Infectious Immunology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infectious Immunology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infectious Immunology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infectious Immunology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infectious Immunology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infectious Immunology Revenue Breakdown by Application (2018-2029)
4 Infectious Immunology Competition Analysis by Players
4.1 Global Infectious Immunology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Immunology as of 2022)
4.3 Date of Key Players Enter into Infectious Immunology Market
4.4 Global Top Players Infectious Immunology Headquarters and Area Served
4.5 Key Players Infectious Immunology Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Immunology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Infectious Immunology Products, Services and Solutions
5.1.4 Abbott Laboratories Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Roche Diagnostics
5.2.1 Roche Diagnostics Profile
5.2.2 Roche Diagnostics Main Business
5.2.3 Roche Diagnostics Infectious Immunology Products, Services and Solutions
5.2.4 Roche Diagnostics Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Diagnostics Recent Developments
5.3 Thermo Fisher Scientifics
5.3.1 Thermo Fisher Scientifics Profile
5.3.2 Thermo Fisher Scientifics Main Business
5.3.3 Thermo Fisher Scientifics Infectious Immunology Products, Services and Solutions
5.3.4 Thermo Fisher Scientifics Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Laboratories Recent Developments
5.4 Bio-Rad Laboratories
5.4.1 Bio-Rad Laboratories Profile
5.4.2 Bio-Rad Laboratories Main Business
5.4.3 Bio-Rad Laboratories Infectious Immunology Products, Services and Solutions
5.4.4 Bio-Rad Laboratories Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Laboratories Recent Developments
5.5 Dr. Reddy’s Laboratories
5.5.1 Dr. Reddy’s Laboratories Profile
5.5.2 Dr. Reddy’s Laboratories Main Business
5.5.3 Dr. Reddy’s Laboratories Infectious Immunology Products, Services and Solutions
5.5.4 Dr. Reddy’s Laboratories Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.5.5 Dr. Reddy’s Laboratories Recent Developments
5.6 AbbVie Inc
5.6.1 AbbVie Inc Profile
5.6.2 AbbVie Inc Main Business
5.6.3 AbbVie Inc Infectious Immunology Products, Services and Solutions
5.6.4 AbbVie Inc Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.6.5 AbbVie Inc Recent Developments
5.7 Janssen Global Services
5.7.1 Janssen Global Services Profile
5.7.2 Janssen Global Services Main Business
5.7.3 Janssen Global Services Infectious Immunology Products, Services and Solutions
5.7.4 Janssen Global Services Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.7.5 Janssen Global Services Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Infectious Immunology Products, Services and Solutions
5.8.4 Johnson & Johnson Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 Amgen Inc
5.9.1 Amgen Inc Profile
5.9.2 Amgen Inc Main Business
5.9.3 Amgen Inc Infectious Immunology Products, Services and Solutions
5.9.4 Amgen Inc Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.9.5 Amgen Inc Recent Developments
5.10 Pfizer Inc
5.10.1 Pfizer Inc Profile
5.10.2 Pfizer Inc Main Business
5.10.3 Pfizer Inc Infectious Immunology Products, Services and Solutions
5.10.4 Pfizer Inc Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.10.5 Pfizer Inc Recent Developments
5.11 Novartis
5.11.1 Novartis Profile
5.11.2 Novartis Main Business
5.11.3 Novartis Infectious Immunology Products, Services and Solutions
5.11.4 Novartis Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.11.5 Novartis Recent Developments
5.12 Astellas
5.12.1 Astellas Profile
5.12.2 Astellas Main Business
5.12.3 Astellas Infectious Immunology Products, Services and Solutions
5.12.4 Astellas Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.12.5 Astellas Recent Developments
5.13 Bristol-Myers Squibb Company
5.13.1 Bristol-Myers Squibb Company Profile
5.13.2 Bristol-Myers Squibb Company Main Business
5.13.3 Bristol-Myers Squibb Company Infectious Immunology Products, Services and Solutions
5.13.4 Bristol-Myers Squibb Company Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.13.5 Bristol-Myers Squibb Company Recent Developments
5.14 Merck Sharp & Dohme Corp
5.14.1 Merck Sharp & Dohme Corp Profile
5.14.2 Merck Sharp & Dohme Corp Main Business
5.14.3 Merck Sharp & Dohme Corp Infectious Immunology Products, Services and Solutions
5.14.4 Merck Sharp & Dohme Corp Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.14.5 Merck Sharp & Dohme Corp Recent Developments
5.15 UCB SA
5.15.1 UCB SA Profile
5.15.2 UCB SA Main Business
5.15.3 UCB SA Infectious Immunology Products, Services and Solutions
5.15.4 UCB SA Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.15.5 UCB SA Recent Developments
5.16 Allergan
5.16.1 Allergan Profile
5.16.2 Allergan Main Business
5.16.3 Allergan Infectious Immunology Products, Services and Solutions
5.16.4 Allergan Infectious Immunology Revenue (US$ Million) & (2018-2023)
5.16.5 Allergan Recent Developments
6 North America
6.1 North America Infectious Immunology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infectious Immunology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infectious Immunology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infectious Immunology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infectious Immunology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infectious Immunology Market Dynamics
11.1 Infectious Immunology Industry Trends
11.2 Infectious Immunology Market Drivers
11.3 Infectious Immunology Market Challenges
11.4 Infectious Immunology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
